Zomedica Pharmaceuticals Corp Stock Alpha and Beta Analysis
| ZOM Stock | USD 0.12 0 2.50% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Zomedica Pharmaceuticals Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Zomedica Pharmaceuticals over a specified time horizon. Remember, high Zomedica Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Zomedica Pharmaceuticals' market risk premium analysis include:
Beta 0.59 | Alpha (0.12) | Risk 4.02 | Sharpe Ratio (0.01) | Expected Return (0.05) |
Zomedica Pharmaceuticals Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Zomedica |
Zomedica Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Zomedica Pharmaceuticals market risk premium is the additional return an investor will receive from holding Zomedica Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Zomedica Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Zomedica Pharmaceuticals' performance over market.| α | -0.12 | β | 0.59 |
Zomedica Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Zomedica Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Zomedica Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Zomedica Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Zomedica Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zomedica Pharmaceuticals shares will generate the highest return on investment. By understating and applying Zomedica Pharmaceuticals stock market price indicators, traders can identify Zomedica Pharmaceuticals position entry and exit signals to maximize returns.
Zomedica Pharmaceuticals Return and Market Media
The median price of Zomedica Pharmaceuticals for the period between Sat, Sep 14, 2024 and Fri, Dec 13, 2024 is 0.13 with a coefficient of variation of 5.1. The daily time series for the period is distributed with a sample standard deviation of 0.01, arithmetic mean of 0.13, and mean deviation of 0.0. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Zomedica Corp Q2 2024 Earnings Call Highlights Diagnostics Surge Amid Revenue Challenges | 10/09/2024 |
2 | Acquisition by Ann Cotter of 8333 shares of Zomedica Pharmaceuticals at 0.11 subject to Rule 16b-3 | 10/14/2024 |
3 | ZOM - Zomedica Corp. Latest Stock News Market Updates - StockTitan | 10/24/2024 |
4 | Acquisition by Anthony Blair of 150000 shares of Zomedica Pharmaceuticals at 0.123 subject to Rule 16b-3 | 11/08/2024 |
5 | Acquisition by Russell Klass of 210200 shares of Zomedica Pharmaceuticals at 0.12 subject to Rule 16b-3 | 11/11/2024 |
6 | Acquisition by Robert Cohen of 1823107 shares of Zomedica Pharmaceuticals at 0.13 subject to Rule 16b-3 | 11/13/2024 |
About Zomedica Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Zomedica or other stocks. Alpha measures the amount that position in Zomedica Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 35.94 | 31.85 | 49.64 | PTB Ratio | 0.6 | 0.82 | 0.78 |
Zomedica Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Zomedica Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zomedica Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Zomedica Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Zomedica Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Zomedica Pharmaceuticals' management manipulating its earnings.
| 20th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Zomedica Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Zomedica Pharmaceuticals Backtesting, Zomedica Pharmaceuticals Valuation, Zomedica Pharmaceuticals Correlation, Zomedica Pharmaceuticals Hype Analysis, Zomedica Pharmaceuticals Volatility, Zomedica Pharmaceuticals History and analyze Zomedica Pharmaceuticals Performance. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Zomedica Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.